Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Disorders of Erythrocytes

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Effect of surgery of pulmonary cysts related to immunoglobulin light chain deposits].

Revue des maladies respiratoires·2020

Same author

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Same author

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Same author

Bcl-2 protein family expression pattern determines synergistic pro-apoptotic effects of BH3 mimetics with hemisynthetic cardiac glycoside UNBS1450 in acute myeloid leukemia.

Leukemia·2016

Same author

Cell type-dependent ROS and mitophagy response leads to apoptosis or necroptosis in neuroblastoma.

Oncogene·2015

Same author

Early downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450.

Cell death & disease·2015

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron

Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron

Published on: February 23, 2024

Anemia in cancer.

M Dicato¹, L Plawny, M Diederich

¹Laboratory of the Foundation for Research in Cancer and Blood Disorders, Centre Hospitalier de Luxembourg, Luxembourg. mdicato@gmail.com

Annals of Oncology : Official Journal of the European Society for Medical Oncology

|October 15, 2010

Summary

Anemia in cancer patients involves inflammatory cytokines and genetic factors affecting red blood cell production. Current therapies like iron and erythropoietin face challenges and evolving guidelines.

Area of Science:

Oncology
Hematology
Immunology

Background:

Inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), are key in cancer-related anemia.
These cytokines impact erythropoiesis through inflammatory pathways and genetic regulation involving GATA-1 and GATA-2.

Purpose of the Study:

To review the multifaceted pathophysiology of anemia in cancer patients.
To discuss current and emerging therapeutic strategies for cancer-related anemia.

Main Methods:

Literature review of inflammatory cytokine roles in cancer anemia.
Analysis of genetic regulatory factors in erythropoiesis.
Examination of therapeutic approaches including iron, transfusions, and erythropoietin.

More Related Videos

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Related Experiment Videos

Last Updated: Jun 8, 2026

Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron

Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron

Published on: February 23, 2024

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Main Results:

Complex inflammatory mechanisms and genetic factors (GATA-1, GATA-2) contribute to cancer anemia.
Iron therapy is increasingly utilized.
Late transfusion side effects remain unclear, and erythropoietin use is under scrutiny with new guidelines.

Conclusions:

Understanding the interplay of inflammation, genetics, and therapy is crucial for managing cancer-related anemia.
Evolving recommendations guide the use of erythropoiesis-stimulating agents and other treatments.